Wentao Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wentao Zhang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Tianze Sun
Department of Trauma and Orthopedics, Peking University People's Hospital, Beijing, 100044, China
7 shared publications - Zhonghai Li
Department of Orthopedics, First Affiliated Hospital of Dalian Medical University
7 shared publications - Jing Zhang
Department of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
5 shared publications - Ming Yang
Department of Orthopaedics
3 shared publications - Huagui Huang
Department of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
2 shared publications - Jinzuo Wang
Department of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
2 shared publications
Latest Publications
- Open Access
- 23 May 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (6) , 627
The Digital Twin: A Potential Solution for the Personalized Diagnosis and Treatment of Musculoskeletal System Diseases
Due to the high prevalence and rates of disability associated with musculoskeletal system diseases, more thorough research into diagnosis, pathogenesis, and treatments is required. One of the key contributors to the emergence of diseases of the musculoskeletal system is thought to be changes in the biomechanics of the human musculoskeletal system. However, there are some defects concerning personal analysis or dynamic responses in current biomechanical research methodologies. Digital twin (DT) was initially an engineering concept that reflected the mirror image of a physical entity. With the application of medical image analysis and artificial intelligence (AI), it entered our lives and showed its potential to be further applied in the medical field. Consequently, we believe that DT can take a step towards personalized healthcare by guiding the design of industrial personalized healthcare systems. In this perspective article, we discuss the limitations of traditional biomechanical methods and the initial exploration of DT in musculoskeletal system diseases. We provide a new opinion that DT could be an effective solution for musculoskeletal system diseases in the future, which will help us analyze the real-time biomechanical properties of the musculoskeletal system and achieve personalized medicine.
- 23 May 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (6) , 627
Open AccessThe Digital Twin: A Potential Solution for the Personalized Diagnosis and Treatment of Musculoskeletal System Diseases
Due to the high prevalence and rates of disability associated with musculoskeletal system diseases, more thorough research into diagnosis, pathogenesis, and treatments is required. One of the key contributors to the emergence of diseases of the musculoskeletal system is thought to be changes in the biomechanics of the human musculoskeletal system. However, there are some defects concerning personal analysis or dynamic responses in current biomechanical research methodologies. Digital twin (DT) was initially an engineering concept that reflected the mirror image of a physical entity. With the application of medical image analysis and artificial intelligence (AI), it entered our lives and showed its potential to be further applied in the medical field. Consequently, we believe that DT can take a step towards personalized healthcare by guiding the design of industrial personalized healthcare systems. In this perspective article, we discuss the limitations of traditional biomechanical methods and the initial exploration of DT in musculoskeletal system diseases. We provide a new opinion that DT could be an effective solution for musculoskeletal system diseases in the future, which will help us analyze the real-time biomechanical properties of the musculoskeletal system and achieve personalized medicine.
- Open Access
- 26 March 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (4) , 414
Recent Advance of Strontium Functionalized in Biomaterials for Bone Regeneration
Bone defect disease causes damage to people’s lives and property, and how to effectively promote bone regeneration is still a big clinical challenge. Most of the current repair methods focus on filling the defects, which has a poor effect on bone regeneration. Therefore, how to effectively promote bone regeneration while repairing the defects at the same time has become a challenge for clinicians and researchers. Strontium (Sr) is a trace element required by the human body, which mainly exists in human bones. Due to its unique dual properties of promoting the proliferation and differentiation of osteoblasts and inhibiting osteoclast activity, it has attracted extensive research on bone defect repair in recent years. With the deep development of research, the mechanisms of Sr in the process of bone regeneration in the human body have been clarified, and the effects of Sr on osteoblasts, osteoclasts, mesenchymal stem cells (MSCs), and the inflammatory microenvironment in the process of bone regeneration have been widely recognized. Based on the development of technology such as bioengineering, it is possible that Sr can be better loaded onto biomaterials. Even though the clinical application of Sr is currently limited and relevant clinical research still needs to be developed, Sr-composited bone tissue engineering biomaterials have achieved satisfactory results in vitro and in vivo studies. The Sr compound together with biomaterials to promote bone regeneration will be a development direction in the future. This review will present a brief overview of the relevant mechanisms of Sr in the process of bone regeneration and the related latest studies of Sr combined with biomaterials. The aim of this paper is to highlight the potential prospects of Sr functionalized in biomaterials.
- 26 March 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (4) , 414
Open AccessRecent Advance of Strontium Functionalized in Biomaterials for Bone Regeneration
Bone defect disease causes damage to people’s lives and property, and how to effectively promote bone regeneration is still a big clinical challenge. Most of the current repair methods focus on filling the defects, which has a poor effect on bone regeneration. Therefore, how to effectively promote bone regeneration while repairing the defects at the same time has become a challenge for clinicians and researchers. Strontium (Sr) is a trace element required by the human body, which mainly exists in human bones. Due to its unique dual properties of promoting the proliferation and differentiation of osteoblasts and inhibiting osteoclast activity, it has attracted extensive research on bone defect repair in recent years. With the deep development of research, the mechanisms of Sr in the process of bone regeneration in the human body have been clarified, and the effects of Sr on osteoblasts, osteoclasts, mesenchymal stem cells (MSCs), and the inflammatory microenvironment in the process of bone regeneration have been widely recognized. Based on the development of technology such as bioengineering, it is possible that Sr can be better loaded onto biomaterials. Even though the clinical application of Sr is currently limited and relevant clinical research still needs to be developed, Sr-composited bone tissue engineering biomaterials have achieved satisfactory results in vitro and in vivo studies. The Sr compound together with biomaterials to promote bone regeneration will be a development direction in the future. This review will present a brief overview of the relevant mechanisms of Sr in the process of bone regeneration and the related latest studies of Sr combined with biomaterials. The aim of this paper is to highlight the potential prospects of Sr functionalized in biomaterials.
- Open Access
- 22 December 2022
- Published by Elsevier in Materials Today Bio
- Vol. 18, 100528
Construction of artificial periosteum with methacrylamide gelatin hydrogel-wharton's jelly based on stem cell recruitment and its application in bone tissue engineering
- 22 December 2022
- Published by Elsevier in Materials Today Bio
- Vol. 18, 100528
Open AccessConstruction of artificial periosteum with methacrylamide gelatin hydrogel-wharton's jelly based on stem cell recruitment and its application in bone tissue engineering
- Open Access
- 8 November 2022
- Published by JMIR Publications Inc. in JMIR Preprints
The Effectjsaxijasbjjkasnc noplasty: A Rdcsdcstive Stdcsdcsdy (Preprint)
BACKGROUND sdsdcsdcs OBJECTIVE sdcsdcsdcsdc METHODS scsdcsdcsv RESULTS sdcsdcsdc CONCLUSIONS svfvfdv CLINICALTRIAL vfdfvdfvdv
- 8 November 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Effectjsaxijasbjjkasnc noplasty: A Rdcsdcstive Stdcsdcsdy (Preprint)
BACKGROUND sdsdcsdcs OBJECTIVE sdcsdcsdcsdc METHODS scsdcsdcsv RESULTS sdcsdcsdc CONCLUSIONS svfvfdv CLINICALTRIAL vfdfvdfvdv
- Open Access
- 7 November 2022
- Published by Wiley in Stem Cells International
- Vol. 2022, 1-24
The Influence of Intervertebral Disc Microenvironment on the Biological Behavior of Engrafted Mesenchymal Stem Cells
Intervertebral disc degeneration is the main cause of low back pain. Traditional treatment methods cannot repair degenerated intervertebral disc tissue. The emergence of stem cell therapy makes it possible to regenerate and repair degenerated intervertebral disc tissue. At present, mesenchymal stem cells are the most studied, and different types of mesenchymal stem cells have their own characteristics. However, due to the harsh and complex internal microenvironment of the intervertebral disc, it will affect the biological behaviors of the implanted mesenchymal stem cells, such as viability, proliferation, migration, and chondrogenic differentiation, thereby affecting the therapeutic effect. This review is aimed at summarizing the influence of each intervertebral disc microenvironmental factor on the biological behavior of mesenchymal stem cells, so as to provide new ideas for using tissue engineering technology to assist stem cells to overcome the influence of the microenvironment in the future.
- 7 November 2022
- Published by Wiley in Stem Cells International
- Vol. 2022, 1-24
Open AccessThe Influence of Intervertebral Disc Microenvironment on the Biological Behavior of Engrafted Mesenchymal Stem Cells
Intervertebral disc degeneration is the main cause of low back pain. Traditional treatment methods cannot repair degenerated intervertebral disc tissue. The emergence of stem cell therapy makes it possible to regenerate and repair degenerated intervertebral disc tissue. At present, mesenchymal stem cells are the most studied, and different types of mesenchymal stem cells have their own characteristics. However, due to the harsh and complex internal microenvironment of the intervertebral disc, it will affect the biological behaviors of the implanted mesenchymal stem cells, such as viability, proliferation, migration, and chondrogenic differentiation, thereby affecting the therapeutic effect. This review is aimed at summarizing the influence of each intervertebral disc microenvironmental factor on the biological behavior of mesenchymal stem cells, so as to provide new ideas for using tissue engineering technology to assist stem cells to overcome the influence of the microenvironment in the future.
- Top Cited PapersOpen Access
- 13 May 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 34, 22-41
Clinical applications and prospects of 3D printing guide templates in orthopaedics
- 13 May 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 34, 22-41
Top Cited PapersOpen AccessClinical applications and prospects of 3D printing guide templates in orthopaedics
- Top Cited PapersOpen Access
- 16 February 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 33, 41-54
Periosteum and development of the tissue-engineered periosteum for guided bone regeneration
- 16 February 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 33, 41-54
Top Cited PapersOpen AccessPeriosteum and development of the tissue-engineered periosteum for guided bone regeneration
- Open Access
- 27 January 2021
- Published by EDP Sciences in E3S Web of Conferences
- Vol. 233, 02041
Efficacy of Jianpi Huatan Dingxuan Decoction in the Treatment of Vertigo and Phlegm Obstruction Syndrome
Objective: To explore the clinical effect of the application of Jianpi Huatan Dingxuan Decoction in the treatment of patients with vertigo and phlegm obstruction. Method: The research work was started in Henan Provincial Hospital of Traditional Chinese Medicine. The work will be carried out from October 2019 to October 2020. The patients are all patients with vertigo and phlegm obstruction syndrome who received treatment during this period. 100 of them were selected as this time. The study subjects were randomly divided into two groups, the control group given conventional western medicine treatment and the experimental group given Jianpi Huatan Dingxuan Decoction. The treatment effects of the two groups were compared and analyzed. Results: The treatment efficiency and nursing satisfaction of the experimental group were 96.00% and 94.00% respectively, which were significantly higher than the 82.00% and 78.00% of the control group. Before treatment, the vertebrobasilar blood flow velocity of the patients was relatively low, P>0.05. After the treatment intervention, the vertebral artery blood flow velocity and the basilar artery blood flow velocity of the experimental group were significantly higher than those of the control group. The data differed greatly. P<0.05, the experimental group had better results. Conclusion: The application of Jianpi Huatan Dingxuan Decoction in the treatment of patients with vertigo and phlegm obstruction has a significant effect, which can promote the recovery of patients, improve the effective rate of clinical treatment, and has positive significance for clinical development.
- 27 January 2021
- Published by EDP Sciences in E3S Web of Conferences
- Vol. 233, 02041
Open AccessEfficacy of Jianpi Huatan Dingxuan Decoction in the Treatment of Vertigo and Phlegm Obstruction Syndrome
Objective: To explore the clinical effect of the application of Jianpi Huatan Dingxuan Decoction in the treatment of patients with vertigo and phlegm obstruction. Method: The research work was started in Henan Provincial Hospital of Traditional Chinese Medicine. The work will be carried out from October 2019 to October 2020. The patients are all patients with vertigo and phlegm obstruction syndrome who received treatment during this period. 100 of them were selected as this time. The study subjects were randomly divided into two groups, the control group given conventional western medicine treatment and the experimental group given Jianpi Huatan Dingxuan Decoction. The treatment effects of the two groups were compared and analyzed. Results: The treatment efficiency and nursing satisfaction of the experimental group were 96.00% and 94.00% respectively, which were significantly higher than the 82.00% and 78.00% of the control group. Before treatment, the vertebrobasilar blood flow velocity of the patients was relatively low, P>0.05. After the treatment intervention, the vertebral artery blood flow velocity and the basilar artery blood flow velocity of the experimental group were significantly higher than those of the control group. The data differed greatly. P<0.05, the experimental group had better results. Conclusion: The application of Jianpi Huatan Dingxuan Decoction in the treatment of patients with vertigo and phlegm obstruction has a significant effect, which can promote the recovery of patients, improve the effective rate of clinical treatment, and has positive significance for clinical development.
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
The Dual Effect of Abnormal Serum Uric Acid on Intervertebral Disc Degeneration
An abnormal serum uric acid (SUA) level is associated with many diseases. To our knowledge, there is no research on the association between SUA and intervertebral disc degeneration (IDD). The purpose of this study was to determine the relationship between SUA and IDD. From June 2011 to July 2020, 691 patients undergoing surgery for lumbar disc herniation (LDH) were included in the LDH group, and 684 patients who underwent endoscopic surgery for knee trauma were included in the non‐LDH group. We examined the baseline characteristics of all these patients and divided the SUA level into 10 groups according to the percentiles in males, females, and the total population. Subsequently, the relationship between the SUA level and IDD was further analyzed. There was no statistically significant difference in the baseline characteristics of the two groups (p > 0.05). Among the 10 groups, the LDH rate was higher at both lower and higher SUA levels. In multiple logistic regression analysis, after adjustment for age, sex, body mass index, smoking, and drinking, when the SUA level was 80%, compared with 60–80%, the odds ratio (OR) and 95% confidence interval (CI) of LDH of the total population were 1.821 (1.125–2.946) and 1.701 (1.186–2.438), respectively, and in the males, they were 1.922 (1.169–3.161) and 2.800 (1.766, 4.439), respectively. In females, when the SUA was <20%, there was a higher LDH rate (OR = 1.951, 95% CI 1.091‐3.486). The present study suggests that there is a U‐shaped relationship between SUA and IDD, being particularly prominent among male. Lower and higher SUA level may be risk factors for IDD.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessThe Dual Effect of Abnormal Serum Uric Acid on Intervertebral Disc Degeneration
An abnormal serum uric acid (SUA) level is associated with many diseases. To our knowledge, there is no research on the association between SUA and intervertebral disc degeneration (IDD). The purpose of this study was to determine the relationship between SUA and IDD. From June 2011 to July 2020, 691 patients undergoing surgery for lumbar disc herniation (LDH) were included in the LDH group, and 684 patients who underwent endoscopic surgery for knee trauma were included in the non‐LDH group. We examined the baseline characteristics of all these patients and divided the SUA level into 10 groups according to the percentiles in males, females, and the total population. Subsequently, the relationship between the SUA level and IDD was further analyzed. There was no statistically significant difference in the baseline characteristics of the two groups (p > 0.05). Among the 10 groups, the LDH rate was higher at both lower and higher SUA levels. In multiple logistic regression analysis, after adjustment for age, sex, body mass index, smoking, and drinking, when the SUA level was 80%, compared with 60–80%, the odds ratio (OR) and 95% confidence interval (CI) of LDH of the total population were 1.821 (1.125–2.946) and 1.701 (1.186–2.438), respectively, and in the males, they were 1.922 (1.169–3.161) and 2.800 (1.766, 4.439), respectively. In females, when the SUA was <20%, there was a higher LDH rate (OR = 1.951, 95% CI 1.091‐3.486). The present study suggests that there is a U‐shaped relationship between SUA and IDD, being particularly prominent among male. Lower and higher SUA level may be risk factors for IDD.
- Open Access
- 1 September 2020
- Published by EDP Sciences in E3S Web of Conferences
- Vol. 185, 03011
Clinical Study on Treatment of Patients with Acute Cerebral Infarction by Huayu Tongluo Decoction Combined with Edaravone Injection
To study the clinical effect of Huayu Tongluo Decoction combined with edaravone injection in the treatment of patients with acute cerebral infarction.86 patients with acute cerebral infarction received from our hospital from October 2016 to May 2018 were randomly divided into study group (n=43) and control group (n=43). Routine treatment was performed in both groups. On the basis of this, the control group was treated with edaravone injection, and the research group was treated with Huayu Tongluo Decoction combined with edaravone injection. The effects of treatment, the degree of neurological deficit (NIHSS score), TCM syndrome scores and quality of life (QLI score) before and after treatment were compared. The total effective rate of the study group [95.35% (41/43)] was higher than that of the control group [79.07% (34/43)] (P<0.05). After treatment, the main symptoms, secondary diseases and tongue and pulse of the two groups were treated. The scores were lower than before treatment, and the study group was lower than the control group (P<0.05). After treatment, the NIHSS and QLI scores of the two groups were better than before treatment, and the NIHSS score of the study group was lower than that of the control group, and the QLI score was higher than the control. Group (P<0.05). The clinical effect of Huayu Tongluo Decoction combined with edaravone injection in the treatment of patients with acute cerebral infarction is significant, which can further improve the clinical symptoms, improve neurological function and improve the quality of life.
- 1 September 2020
- Published by EDP Sciences in E3S Web of Conferences
- Vol. 185, 03011
Open AccessClinical Study on Treatment of Patients with Acute Cerebral Infarction by Huayu Tongluo Decoction Combined with Edaravone Injection
To study the clinical effect of Huayu Tongluo Decoction combined with edaravone injection in the treatment of patients with acute cerebral infarction.86 patients with acute cerebral infarction received from our hospital from October 2016 to May 2018 were randomly divided into study group (n=43) and control group (n=43). Routine treatment was performed in both groups. On the basis of this, the control group was treated with edaravone injection, and the research group was treated with Huayu Tongluo Decoction combined with edaravone injection. The effects of treatment, the degree of neurological deficit (NIHSS score), TCM syndrome scores and quality of life (QLI score) before and after treatment were compared. The total effective rate of the study group [95.35% (41/43)] was higher than that of the control group [79.07% (34/43)] (P<0.05). After treatment, the main symptoms, secondary diseases and tongue and pulse of the two groups were treated. The scores were lower than before treatment, and the study group was lower than the control group (P<0.05). After treatment, the NIHSS and QLI scores of the two groups were better than before treatment, and the NIHSS score of the study group was lower than that of the control group, and the QLI score was higher than the control. Group (P<0.05). The clinical effect of Huayu Tongluo Decoction combined with edaravone injection in the treatment of patients with acute cerebral infarction is significant, which can further improve the clinical symptoms, improve neurological function and improve the quality of life.